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Fig. 1S Schematic structure of LDHs. 
 
Fig. 2S Experimental setup for the CF reactions. 
 
Fig. 3S FT-IR spectra of the Cu(II)Fe(III)-LDH: as-prepared material (a), after the 10-hour long synthesis (b). 
 
Fig. 4S. Elemental map of the as-prepared Cu(II)Fe(III)-LDH. 
(a) (b) 
 S3 
 
Fig. 5S TG/dTG curves of the as-prepared Cu(II)Fe(III)-LDH. 
 
Fig. 6S XPS spectra indicating the presence of only Cu(II) ions for the as-prepared material (a) and as well as for 
the LDH sample after the 10-hour long run. 
Table 1S Elemental composition of the Cu(II)Fe(III)-LDH determined by ICP−AES. 
Sample 
Cu  Fe 
Cu/Fe 
wt% mmol/g  wt% mmol/g 
as-prepared 32.4510 5.107  16.2111 2.903 1.76 
after the 10-hour long run 32.4422 5.105  16.2084 2.902 1.76 
(b) (a) 
 S4 
1-Benzyl-4-phenyl-1H-1,2,3-triazole, 1: 
 
White solid; mp: 121–124 °C (lit.[S1] mp: 123–125 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 5.60 (s, 2H, CH2), 7.31–7.38 (m, 
3H, Ar-H), 7.38–7.47 (m, 5H, Ar-H), 7.70 (s, 1H, Ar-H), 7.80–7.88 (d, 2H, Ar-H, J=7.8 Hz). 
1-(2-Fluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 2: 
 
White solid; mp: 87–91 °C (lit.[S2] mp: 89–92 °C); NMR data is in agreement with the 
literature reference.
[S3] 1
H NMR (400.1 MHz, CDCl3) δH: 5.63 (s, 2H, CH2), 7.07–7.21 (m, 
2H, Ar-H), 7.27–7.47 (m, 5H, Ar-H), 7.77 (s, 1H, Ar-H), 7.78–7.86 (d, 2H, Ar-H, J=7.8 Hz). 
1-(4-Fluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 3: 
 
White solid; mp: 130–133 °C (lit.[S4] mp: 129–131 °C); NMR data is in agreement with the 
literature reference.
[S4] ] 1
H NMR (400.1 MHz, CDCl3) δH: 5.52 (s, 2H, CH2), 6.98–7.11 (t, 
2H, Ar-H, J=8.1 Hz), 7.23–7.35 (m, 3H, Ar-H), 7.36–7.45 (m, 2H, Ar-H), 7.67 (s, 1H, Ar-H), 
7.74–7.85 (d, 2H, Ar-H, J=7.4 Hz). 
1-(2,5-Difluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 4: 
 
White solid; mp: 100–103 °C (lit.[S2] mp: 98–102 °C); NMR data is in agreement with the 
literature reference.
[S2] 1
H NMR (400.1 MHz, CDCl3) δH: 5.61 (s, 2H, CH2), 6.93–7.16 (m, 
3H, Ar-H), 7.29–7.36 (m, 1H, Ar-H), 7.37–7.46 (m, 2H, Ar-H), 7.73–7.89 (m, 3H, Ar-H). 
 S5 
1-(2-Chlorobenzyl)-4-phenyl-1H-1,2,3-triazole, 5: 
 
White solid; mp: 80–83 °C (lit.[S5] mp: 79–81 °C); NMR data is in agreement with the 
literature reference.
[S5] 1
H NMR (400.1 MHz, CDCl3) δH: 5.71 (s, 2H, CH2), 7.18–7.35 (m, 
4H, Ar-H), 7.36–7.48 (m, 3H, Ar-H), 7.78 (s, 1H, Ar-H), 7.79–7.88 (d, 2H, Ar-H, J=7.8 Hz). 
1-(4-Nitrobenzyl)-4-phenyl-1H-1,2,3-triazole, 6: 
 
Yellowish solid; mp: 156–159 °C (lit.[S1] mp: 158–159 °C); NMR data is in agreement with 
the literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 5.71 (s, 2H, CH2), 7.30–7.40 (t, 
1H, Ar-H, J=7.9 Hz), 7.40–7.50 (m, 4H, Ar-H), 7.77 (s, 1H, Ar-H), 7.80–7.88 (d, 2H, Ar-H, 
J=7.7 Hz), 8.20–8.31 (d, 2H, Ar-H, J=8.3 Hz). 
1-(2-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole, 7: 
 
White solid; mp: 91–94 °C (lit.[S6] mp: 94–95 °C); NMR data is in agreement with the 
literature reference.
[S6] 1
H NMR (400.1 MHz, CDCl3) δH: 2.32 (s, 3H, CH3), 5.56 (s, 2H, 
CH2), 7.18–7.27 (m, 3H, Ar-H), 7.27–7.34 (m, 2H, Ar-H), 7.35–7.43 (t, 2H, Ar-H, J=7.3 Hz), 
7.55 (s, 1H, Ar-H), 7.75–7.84 (d, 2H, Ar-H, J=7.3 Hz). 
1-(4-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole, 8: 
 
White solid; mp: 92–94 °C (lit.[S1] mp: 93–95 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 2.36 (s, 3H, CH3), 5.52 (s, 2H, 
CH2), 7.15–7.25 (m, 4H, Ar-H), 7.29–7.34 (m, 1H, Ar-H), 7.35–7.43 (m, 2H, Ar-H),7.65 (s, 
1H, Ar-H), 7.75–7.83 (d, 2H, Ar-H, J=7.4 Hz). 
 S6 
1-(Naphthalen-1-ylmethyl)-4-phenyl-1H-1,2,3-triazole, 9: 
 
White solid; mp: 138–141 °C (lit.[S7] mp: 141–142 °C); NMR data is in agreement with the 
literature reference.
[S7] 1
H NMR (400.1 MHz, CDCl3) δH: 5.76 (s, 2H, CH2), 7.30–7.37 (m, 
1H, Ar-H), 7.38–7.45 (m, 3H, Ar-H), 7.50–7.59 (m, 2H, Ar-H), 7.71 (s, 1H, Ar-H), 7.78–7.92 
(m, 6H, Ar-H).
 
1-Phenethyl-4-phenyl-1H-1,2,3-triazole, 10: 
 
White solid; mp: 139–142 °C (lit.[S1] mp: 141–142 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 3.19–3.31 (t, 2H, CH2, J=7.2 Hz), 
4.56–4.68 (t, 2H, CH2, J=7.2 Hz), 7.09–7.18 (d, 2H, Ar-H, J=7.3 Hz), 7.23–7.37 (m, 4H, Ar-
H), 7.37–7.46 (m, 2H, Ar-H), 7.49 (s, 1H, Ar-H), 7.73–7.83 (d, 2H, Ar-H, J=7.3 Hz). 
1-Cyclohexyl-4-phenyl-1H-1,2,3-triazole, 11: 
 
White solid; mp: 106–109 °C (lit.[S1] mp: 108–109 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 1.20–1.37 (m, 1H, CH2), 1.38–1.56 
(m, 2H, CH2), 1.69–1.86 (m, 3H, 2 CH2), 1.86–2.01 (m, 2H, CH2), 2.16–2.32 (m, 2H, CH2), 
4.40–4.54 (m, 1H, CH), 7.28–7.35 (m, 1H, Ar-H), 7.36–7.46 (m, 2H, Ar-H), 7.70–7.90 (m, 
3H, Ar-H). 
3-(4-Phenyl-1H-1,2,3-triazol-1-yl)dihydrofuran-2(3H)-one, 12: 
 
White solid; mp: 138–142 °C (lit.[S1] mp: 140–141 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 2.98–3.20 (m, 2H, CH2), 4.46–4.62 
(m, 1H, CH2), 4.62–4.79 (m, 1H, CH2), 5.30–5.46 (t, 1H, CH, J=9.1 Hz), 7.30–7.39 (m, 1H, 
Ar-H), 7.39–7.49 (m, 2H, Ar-H), 7.77–7.90 (d, 2H, Ar-H, J=7.7 Hz), 8.05 (s, 1H, Ar-H). 
 S7 
Ethyl 5-(4-phenyl-1H-1,2,3-triazol-1-yl)pentanoate, 13: 
 
White solid; mp: 50–53 °C (lit.[S8] mp: 50–53 °C); NMR data is in agreement with the 
literature reference.
[S8] 1
H NMR (400.1 MHz, CDCl3) δH: 1.17–1.29 (m, 3H, CH3), 1.61–1.74 
(m, 2H, CH2), 1.92–2.05 (m, 2H, CH2), 2.23–2.40 (m, 2H, CH2), 4.03–4.17 (m, 2H, CH2), 
4.33–4.45 (m, 2H, CH2), 7.28–7.35 (m, 1H, Ar-H), 7.36–7.45 (m, 2H, Ar-H), 7.72–7.86 (m, 
3H, Ar-H). 
1-Butyl-4-phenyl-1H-1,2,3-triazole, 14: 
 
White solid; mp: 46–49 °C (lit.[S9] mp: 46–47 °C); NMR data is in agreement with the 
literature reference.
[S9] 1
H NMR (400.1 MHz, CDCl3) δH: 0.92–1.04 (t, 3H, CH3, J=7.4 Hz), 
1.36–1.46 (m, 2H, CH2), 1.88–1.99 (m, 2H, CH2), 4.35–4.44 (t, 2H, CH2, J=7.3 Hz), 7.30–
7.37 (m, 1H, Ar-H), 7.38–7.46 (m, 2H, Ar-H), 7.75 (s, 1H, Ar-H), 7.79–7.88 (d, 2H, Ar-H, 
J=7.5 Hz). 
1-(But-3-en-1-yl)-4-phenyl-1H-1,2,3-triazole, 15: 
 
Brownish solid, mp: 40–43 °C (lit.[S10] mp: 42–44 °C); NMR data is in agreement with the 
literature reference.
[S11] 1
H NMR (400.1 MHz, CDCl3) δH: 2.63–2.76 (m, 2H, CH2), 4.38–4.53 
(t, 2H, CH2, J=7.2 Hz), 5.03–5.19 (d, 2H, CH2, J=12.7 Hz), 5.71–5.87 (m, 1H, CH), 7.29–
7.36 (m, 1H, Ar-H), 7.37–7.46 (m, 2H, Ar-H), 7.75 (s, 1H, Ar-H), 7.78–7.87 (d, 2H, Ar-H, 
J=7.4 Hz). 
1-(3-Chloro-2-methylpropyl)-4-phenyl-1H-1,2,3-triazole, 16: 
 
White solid; mp: 48–50 °C (lit.[S8] mp: 50–51 °C); NMR data is in agreement with the 
literature reference.
[S8] 1
H NMR (400.1 MHz, CDCl3) δH: 1.06–1.15 (d, 3H, CH3, J=6.7 Hz), 
2.51–2.64 (m, 1H, CH), ), 3.40–3.52 (m, 2H, CH2), 4.28–4.52 (m, 2H, CH2), 7.28–7.37 (m, 
1H, Ar-H), 7.38–7.47 (m, 2H, Ar-H), 7.75–7.89 (m, 3H, Ar-H). 
 S8 
1-benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazole, 17: 
 
White solid; mp: 140–143 °C (lit.[S1] mp: 143–145 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 3.81 (s, 3H, CH3), 5.53 (s, 2H, 
CH2), 6.88–6.97 (d, 2H, Ar-H, J=8.5 Hz), 7.27–7.41 (m, 5H, Ar-H), 7.59 (s, 1H, Ar-H), 7.69–
7.76 (d, 2H, Ar-H, J=8.6 Hz). 
1-Benzyl-4-propyl-1H-1,2,3-triazole, 18: 
 
Brownish oil; NMR data is in agreement with the literature reference.
[S11] 1
H NMR (400.1 
MHz, CDCl3) δH: 0.93–1.01 (t, 3H, CH3, J=7.2 Hz), 1.64–1.76 (m, 2H, CH2), 2.65–2.76 (t, 
2H, CH2, J=7.6 Hz), 5.52 (s, 2H, CH2), 7.25–7.30 (m, 2H, Ar-H), 7.32–7.45 (m, 4H, Ar-H). 
Ethyl 1-benzyl-1H-1,2,3-triazole-4-carboxylate, 19: 
 
Yellowish solid; mp: 79–82 °C (lit. [S1] mp: 82–83 °C); NMR data is in agreement with the 
literature reference.
[S1] 1
H NMR (400.1 MHz, CDCl3) δH: 1.30–1.46 (t, 3H, CH3, J=7.2 Hz), 
4.32–4.46 (q, 2H, CH2, J=7.1 Hz), 5.59 (s, 2H, CH2), 7.24–7.35 (m, 2H, Ar-H), 7.35–7.46 (m, 
3H, Ar-H), 8.02 (s, 1H, Ar-H). 
(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl acetate, 20: 
 
Yellowish solid; mp: 55–58 °C (lit.[S8] mp: 55–56 °C); NMR data is in agreement with the 
literature reference.
[S8] 1
H NMR (400.1 MHz, CDCl3) δH: 2.05 (s, 3H, CH3), 5.20 (s, 2H, 
CH2), 5.52 (s, 2H, CH2), 7.23–7.31 (m, 2H, Ar-H), 7.34–7.41 (m, 3H, Ar-H), 7.57 (s, 1H, Ar-
H). 
4-(1-Benzyl-1H-1,2,3-triazol-4-yl)butanenitrile, 21: 
 
 S9 
White solid; mp: 61–64 °C (lit.[S8] mp: 64–66 °C); NMR data is in agreement with the 
literature reference.
[S8] 1
H NMR (400.1 MHz, CDCl3) δH: 2.05–2.14 (m, 2H, CH2), 2.40–2.47 
(t, 2H, CH2, J=7.0 Hz), 2.83–2.91 (t, 2H, CH2, J=7.20 Hz), 5.53 (s, 2H, CH2), 7.27–7.32 (m, 
3H, Ar-H), 7.36–7.45 (m, 3H, Ar-H). 
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)benzamide, 22: 
 
White solid; mp: 125–128 °C (lit.[S10] mp: 126–128 °C); NMR data is in agreement with the 
literature reference.
[S12] ] 1
H NMR (400.1 MHz, CDCl3) δH: 4.69–4.75 (d, 2H, CH2, J=5.6 Hz), 
5.55 (s, 2H, CH2), 6.86 (m, 1H, NH), 7.31–7.34 (m, 1H, Ar-H), 7.37–7.50 (m, 5H, Ar-H), 
7.51–7.58 (m, 2H, Ar-H), 7.77–7.84 (m, 2H, Ar-H). 
1-Benzyl-4-ferrocenyl-1H-1,2,3-triazole, 23: 
 
Golden yellow solid; mp: 147–150 °C (lit. [S13] mp: 145–147 °C); NMR data is in agreement 
with the literature reference.
[S3] 1
H NMR (400.1 MHz, CDCl3) δH: 4.08 (s, 5H, Ar-H), 4.27–
4.32 (m, 2H, Ar-H), 4.68–4.75 (m, 2H, Ar-H), 5.58 (s, 2H, CH2), 7.31–7.34 (m, 2H, Ar-H), 
7.35–7.45 (m, 4H, Ar-H). 
Diethyl 1-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate, 24: 
 
Colorless oil; NMR data is in agreement with the literature reference.
[S14] 1
H NMR (400.1 
MHz, CDCl3) δH: 1.26–1.33 (t, 3H, CH3, J=7.3 Hz), 1.39–1.44 (t, 3H, CH3, J=7.3 Hz), 4.31–
4.40 (q, 2H, CH2, J=7.3 Hz), 4.41–4.50 (q, 2H, CH2, J=7.3 Hz), 5.85 (s, 2H, CH2), 7.26–7.31 
(m, 3H, Ar-H), 7.33–7.38 (m, 2H, Ar-H). 
 S10 
1-Benzyl-4-phenyl-1H-1,2,3-triazole, 1, 
1
H NMR in CDCl3: 
 
1-(2-Fluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 2, 
1
H NMR in CDCl3: 
 
 S11 
1-(4-Fluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 3, 
1
H NMR in CDCl3: 
 
1-(2,5-Difluorobenzyl)-4-phenyl-1H-1,2,3-triazole, 4, 
1
H NMR in CDCl3: 
 
 S12 
1-(2-Chlorobenzyl)-4-phenyl-1H-1,2,3-triazole, 5, 
1
H NMR in CDCl3: 
 
1-(4-Nitrobenzyl)-4-phenyl-1H-1,2,3-triazole, 6, 
1
H NMR in CDCl3: 
 
 S13 
1-(2-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole, 7, 
1
H NMR in CDCl3: 
 
1-(4-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole, 8, 
1
H NMR in CDCl3: 
 
 S14 
1-(Naphthalen-1-ylmethyl)-4-phenyl-1H-1,2,3-triazole, 9, 
1
H NMR in CDCl3: 
 
1-Phenethyl-4-phenyl-1H-1,2,3-triazole, 10, 
1
H NMR in CDCl3: 
 
 S15 
1-Cyclohexyl-4-phenyl-1H-1,2,3-triazole, 11, 
1
H NMR in CDCl3: 
 
3-(4-Phenyl-1H-1,2,3-triazol-1-yl)dihydrofuran-2(3H)-one, 12, 
1
H NMR in CDCl3: 
 
 S16 
Ethyl 5-(4-phenyl-1H-1,2,3-triazol-1-yl)pentanoate, 13, 
1
H NMR in CDCl3: 
 
1-Butyl-4-phenyl-1H-1,2,3-triazole, 14, 
1
H NMR in CDCl3: 
 
 S17 
1-(But-3-en-1-yl)-4-phenyl-1H-1,2,3-triazole, 15, 
1
H NMR in CDCl3: 
 
1-(3-Chloro-2-methylpropyl)-4-phenyl-1H-1,2,3-triazole, 16, 
1
H NMR in CDCl3: 
 
 S18 
1-benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazole, 17, 
1
H NMR in CDCl3: 
 
1-Benzyl-4-propyl-1H-1,2,3-triazole, 18, 
1
H NMR in CDCl3: 
 
 S19 
Ethyl 1-benzyl-1H-1,2,3-triazole-4-carboxylate, 19, 
1
H NMR in CDCl3: 
 
(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl acetate, 20, 
1
H NMR in CDCl3: 
 
 S20 
4-(1-Benzyl-1H-1,2,3-triazol-4-yl)butanenitrile, 21, 
1
H NMR in CDCl3: 
 
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)benzamide, 22, 
1
H NMR in CDCl3: 
 
 S21 
1-Benzyl-4-ferrocenyl-1H-1,2,3-triazole, 23, 
1
H NMR in CDCl3: 
 
Diethyl 1-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate, 24, 
1
H NMR in CDCl3: 
 
 S22 
The test reactions to check the efficacy of the individual LDH components (Cu(NO3)2·3H2O 
and Fe(NO3)3·9H2O) were carried out as follows. 
The benzyl azide‒phenylacetylene model reaction (1 equiv. azide, 1.5 equiv. alkyne, 
cazide=0.085 M) was repeated in a flask with 10 mol% of Cu(NO3)2·3H2O and then with 10 
mol% of Fe(NO3)3·9H2O in 5 mL acetonitrile as solvent (the metal salts were not soluble in 
CH2Cl2). After 6 hours of stirring at reflux temperature, the mixture was concentrated under 
vacuum and was worked up with aqueous NaCl solution and CH2Cl2. The combined organic 
layers were dried over Na2SO4 and concentrated under reduced pressure. No traces of triazole 
products was found according to 
1
H NMR measurements with either of the metal salts. 
 S23 
Continuous-flow oxidative homocoupling of 4-ethynylanisole (in CH2Cl2 as solvent) 
mediated by the Cu(II)Fe(III)-LDH (1 g loaded into the catalyst bed, unused portion), and the 
1
H NMR spectra of the crude product in CDCl3 with signal assignments.
[S15]
 
 
 
 S24 
The test reactions to check the efficacy of the individual LDH components (Cu(NO3)2·3H2O 
and Fe(NO3)3·9H2O) were carried out as follows. 
The benzyl azide‒phenylacetylene model reaction (1 equiv. azide, 1.5 equiv. alkyne, 
cazide=0.085 M) was repeated in a flask with 10 mol% of Cu(NO3)2·3H2O and then with 10 
mol% of Fe(NO3)3·9H2O in 5 mL acetonitrile as solvent (the metal salts were not soluble in 
CH2Cl2). After 6 hours of stirring at reflux temperature, the mixture was concentrated under 
vacuum and was worked up with aqueous NaCl solution and CH2Cl2. The combined organic 
layers were dried over Na2SO4 and concentrated under reduced pressure. No traces of triazole 
products was found according to 
1
H NMR measurements with either of the metal salts. 
 S25 
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